Original Research

Published on 12 Apr 2021

The Central THαβ Immunity Associated Cytokine: IL-10 Has a Strong Anti-Tumor Ability Toward Established Cancer Models In Vivo and Toward Cancer Cells In Vitro

in Cancer Immunity and Immunotherapy

Wan-Chung Hu

Frontiers in Oncology

doi 10.3389/fonc.2021.655554

2,371 views
11 citations

Systematic Review

Published on 12 Apr 2021

Association of Immune Related Adverse Events With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Cancers: A Systemic Review and Meta-analysis

in Cancer Immunity and Immunotherapy

Yong Fan
Wenhui Xie
Hong Huang
Yunxia Wang
Guangtao Li
Yan Geng
Yanjie Hao
Zhuoli Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.633032

6,701 views
69 citations

Original Research

Published on 12 Apr 2021

High TIL, HLA, and Immune Checkpoint Expression in Conventional High-Grade and Dedifferentiated Chondrosarcoma and Poor Clinical Course of the Disease

in Cancer Immunity and Immunotherapy

Sjoerd P. F. T. Nota
Ahmad Al-Sukaini
Shalin S. Patel
Francesco Sabbatino
G. Petur Nielsen
Vikram Deshpande
Jennifer H. Yearley
Soldano Ferrone
Xinhui Wang
Joseph H. Schwab

Frontiers in Oncology

doi 10.3389/fonc.2021.598001

2,462 views
4 citations

Original Research

Published on 12 Apr 2021

The Efficacy and Safety of Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer: A Prospective Clinical Study

in Cancer Immunity and Immunotherapy

Dongxu Wang
Xu Yang
Junyu Long
Jianzhen Lin
Jinzhu Mao
Fucun Xie
Yunchao Wang
Yanyu Wang
Ziyu Xun
Yi Bai

Frontiers in Oncology

doi 10.3389/fonc.2021.646979

5,950 views
35 citations

Original Research

Published on 02 Apr 2021

Characterization of Immune Infiltration and Construction of a Prediction Model for Overall Survival in Melanoma Patients

in Cancer Immunity and Immunotherapy

Gang Li
Xuran Zhu
Chao Liu

Frontiers in Oncology

doi 10.3389/fonc.2021.639059

5,436 views
9 citations

Original Research

Published on 01 Apr 2021

An Immune Cell-Based Signature Associating With EMT Phenotype Predicts Postoperative Overall Survival of ESCC

in Cancer Immunity and Immunotherapy

Hongliang Yu
Dayong Gu
Chao Yue
Jianhua Xu
Feng Yan
Xia He

Frontiers in Oncology

doi 10.3389/fonc.2021.636479

4,556 views
6 citations

Original Research

Published on 01 Apr 2021

Characterization of the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma Using Imaging Mass Cytometry

in Cancer Immunity and Immunotherapy

Ran Li
Ying Lin
Yu Wang
Shaoyuan Wang
Yang Yang
Xinlin Mu
Yusheng Chen
Zhancheng Gao

Frontiers in Oncology

doi 10.3389/fonc.2021.620989

6,428 views
23 citations

Original Research

Published on 01 Apr 2021

Serum Levels of Soluble Urokinase Plasminogen Activator Receptor Predict Tumor Response and Outcome to Immune Checkpoint Inhibitor Therapy

in Cancer Immunity and Immunotherapy

Sven H. Loosen
Joao Gorgulho
Markus S. Jördens
Maximilian Schulze-Hagen
Fabian Beier
Mihael Vucur
Anne T. Schneider
Christiane Koppe
Alexander Mertens
Jakob N. Kather

Frontiers in Oncology

doi 10.3389/fonc.2021.646883

4,200 views
10 citations

Review

Published on 01 Apr 2021

Strategies for Dodging the Obstacles in CAR T Cell Therapy

in Cancer Immunity and Immunotherapy

Pooria Safarzadeh Kozani
Pouya Safarzadeh Kozani
Fatemeh Rahbarizadeh
Shahryar Khoshtinat Nikkhoi

Frontiers in Oncology

doi 10.3389/fonc.2021.627549

13,186 views
43 citations

Review

Published on 31 Mar 2021

B7 Family Members in Lymphoma: Promising Novel Targets for Tumor Immunotherapy?

in Cancer Immunity and Immunotherapy

Wei Zhang
Yu Qiu
Xiaoli Xie
Yao Fu
Lijuan Wang
Zhen Cai

Frontiers in Oncology

doi 10.3389/fonc.2021.647526

5,927 views
8 citations

Original Research

Published on 30 Mar 2021

Inhibition of LDH-A by Oxamate Enhances the Efficacy of Anti-PD-1 Treatment in an NSCLC Humanized Mouse Model

in Cancer Immunity and Immunotherapy

Tianyun Qiao
Yanlu Xiong
Yangbo Feng
Wenwen Guo
Yongsheng Zhou
Jinbo Zhao
Tao Jiang
Changhong Shi
Yong Han

Frontiers in Oncology

doi 10.3389/fonc.2021.632364

13,278 views
58 citations

Original Research

Published on 30 Mar 2021

An Immune-Related Gene Pairs Signature for Predicting Survival in Glioblastoma

in Cancer Immunity and Immunotherapy

Sheng Wang
Xia Xu

Frontiers in Oncology

doi 10.3389/fonc.2021.564960

3,152 views
9 citations

Original Research

Published on 30 Mar 2021

A Local and Low-Dose Chemotherapy/Autophagy-Enhancing Regimen Treatment Markedly Inhibited the Growth of Established Solid Tumors Through a Systemic Antitumor Immune Response

in Cancer Immunity and Immunotherapy

Jia Yuan
Xianlin Yuan
Kunlong Wu
Junxia Gao
Liangping Li

Frontiers in Oncology

doi 10.3389/fonc.2021.658254

4,172 views
9 citations

Case Report

Published on 29 Mar 2021

Case Report: Transarterial Chemoembolization in Combination With Tislelizumab Downstages Unresectable Hepatocellular Carcinoma Followed by Radical Salvage Resection

in Cancer Immunity and Immunotherapy

Jiashuo Chao
Qi Zhu
Desheng Chen
Xiao An
Aiqun Liu
Fei Zhou
Lin Yuan
Zhaowen Wang
Hongcheng Sun

Frontiers in Oncology

doi 10.3389/fonc.2021.667555

5,241 views
19 citations

Review

Published on 29 Mar 2021

Prophylactic Cancer Vaccines Engineered to Elicit Specific Adaptive Immune Response

in Cancer Immunity and Immunotherapy

Davis W. Crews
Jenna A. Dombroski
Michael R. King

Frontiers in Oncology

doi 10.3389/fonc.2021.626463

14,682 views
44 citations

Hypothesis and Theory

Published on 25 Mar 2021

TAM-ing the CIA—Tumor-Associated Macrophages and Their Potential Role in Unintended Side Effects of Therapeutics for Cancer-Induced Anemia

in Cancer Immunity and Immunotherapy

Stefan Weiler
Manfred Nairz

Frontiers in Oncology

doi 10.3389/fonc.2021.627223

4,116 views
3 citations

Navigation group

Articles

The Central THαβ Immunity Associated Cytokine: IL-10 Has a Strong Anti-Tumor Ability Toward Established Cancer Models In Vivo and Toward Cancer Cells In Vitro

Association of Immune Related Adverse Events With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Cancers: A Systemic Review and Meta-analysis

High TIL, HLA, and Immune Checkpoint Expression in Conventional High-Grade and Dedifferentiated Chondrosarcoma and Poor Clinical Course of the Disease

The Efficacy and Safety of Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer: A Prospective Clinical Study

Characterization of Immune Infiltration and Construction of a Prediction Model for Overall Survival in Melanoma Patients

An Immune Cell-Based Signature Associating With EMT Phenotype Predicts Postoperative Overall Survival of ESCC

Characterization of the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma Using Imaging Mass Cytometry

Serum Levels of Soluble Urokinase Plasminogen Activator Receptor Predict Tumor Response and Outcome to Immune Checkpoint Inhibitor Therapy

Strategies for Dodging the Obstacles in CAR T Cell Therapy

B7 Family Members in Lymphoma: Promising Novel Targets for Tumor Immunotherapy?

Inhibition of LDH-A by Oxamate Enhances the Efficacy of Anti-PD-1 Treatment in an NSCLC Humanized Mouse Model

An Immune-Related Gene Pairs Signature for Predicting Survival in Glioblastoma

A Local and Low-Dose Chemotherapy/Autophagy-Enhancing Regimen Treatment Markedly Inhibited the Growth of Established Solid Tumors Through a Systemic Antitumor Immune Response

Case Report: Transarterial Chemoembolization in Combination With Tislelizumab Downstages Unresectable Hepatocellular Carcinoma Followed by Radical Salvage Resection

Prophylactic Cancer Vaccines Engineered to Elicit Specific Adaptive Immune Response

TAM-ing the CIA—Tumor-Associated Macrophages and Their Potential Role in Unintended Side Effects of Therapeutics for Cancer-Induced Anemia